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Combining PDO Threads with 
Exosomes for Microlifting
Diane Irvine Duncan
Abstract
A recent survey of practicing plastic surgeons showed that regenerative 
medicine is the current top interest of esthetic consumers worldwide. Patients 
are frequently requesting correction of small regions, instead of opting for an 
all-encompassing procedure associated with prolonged recovery time. Thus, the 
field of “microlifting” has emerged. This is a new approach in which minimally 
invasive procedures can be utilized to accomplish outcomes formerly reserved 
for traditional surgery. The combination of polydioxanone (PDO) threads and 
topical exosomes is a method of treating both underlying soft tissue laxity and 
the surface of aging skin. The application of exosomes can deliver topical growth 
factors and targeted peptides to assist in rapid skin surface healing. More than 
a simple delivery vesicle, exosomes communicate with cells at the recipient site 
and can induce cellular change. PDO threads can be used subcutaneously as both 
a suspension device and regenerative biostimulatory device. Usually resorbed at 
6 months post-insertion, these threads leave behind a linear network of collagen 
and elastin fibers that remains long after the polydioxanone is gone. Combination 
therapies can target several concerns when performed simultaneously. This 
regenerative method is well accepted by patients due to minimal cost and recov-
ery time.
Keywords: injectable implant, threadlift, exosomes, particulate drug delivery, 
growth factors, PDO threads, filler threads
1. Introduction
The number of practitioners joining the esthetic field is increasing rapidly. 
These specialists range in background and training from aestheticians, chiro-
practors, and acupuncturists to dentists, dermatologists, facial plastic, and plas-
tic surgeons. While more patients are seeking treatment for concerns regarding 
facial and body region challenges, few desire traditional surgical intervention 
with the associated risk and recovery time. Regional differences dictate the 
preferences of the clientele, but many do seek the restoration of their own 
youthful appearance instead of a drastic change. In years past, the emergence of 
stem cell therapy has been viewed by many as a magic wand that could restore 
aging tissues to a youthful state without surgical intervention. Some limitations 
to treatment with mesenchymal stem cells (MSCs) include a low survival rate, 
tumorigenicity, poor “take,” and lack of efficacy [1]. It is thought that many of 
the supposed effects of mesenchymal stem cells are indeed paracrine effects, 
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mediated by acellular factors that are transmitted with the cells, but not by 
direct effects of the cells themselves [2]. For several years, filler companies have 
focused on biostimulatory effects seen after the hyaluronic acid, hydroxyapa-
tite, or other fillers have been metabolized [3, 4]. The injectable poly-L-lactic 
acid works on this principle. A problem can occur when so much filler has been 
injected that the response turns from collagen stimulation to fibrosis. Some 
long-term injectable patients note a “woody” or stiff feeling, difficulty achiev-
ing a natural animated expression, and chronic swelling in a treatment region 
years after the original product was injected. A preferred solution would be 
induction of an existing tissue response using regenerative options now avail-
able and in development. Restoration of dermal thickness, collagen, and elastin 
and self-repair of the adipose framework upon which the skin rests are concepts 
that make sense to our esthetic customer base.
2. Background
Exosomes, also known as secretomes [5], are formed within the cell from 
multivesicular endosomes. Intracellular endosomes contain multiple small 
vesicles measuring 20–200 nm. These multivesicular bodies fuse with the cellular 
plasma membrane, and exocytosis releases spherical particulate carriers now 
identified as exosomes. These acellular bilamellar structures contain miRNA, 
mRNA, and peptides. Exosomes are identified by biomarkers CD9, CD63, 
CD81, Alix, Tsg101, and flotillin-1. The production of exosomes in a laboratory 
involves the use of conditioned media (CM) in a cell culture setting. Usually 
MSCs are the cells cultured. Exosomes can express characteristics of the cells of 
origin, so directed wound care exosomes might be harvested from conditioned 
media used in a co-culture of dermal fibroblasts and adipose-derived stem cells 
(ADSCs). Cell-to-cell communication currently appears to be more important in 
achieving a desired effect than in achieving the direct effect of MSCs themselves 
[6]. An example of this has been seen in a co-culture of dermal fibroblasts and 
mesenchymal stem cells. The formation of “nanotunnels” from cell to cell is 
seen, so cell signaling is somewhat direct. The ability to transfer information 
can also be seen with the endosome/exosome route [7]. Transfection of gene 
products or small peptides through the lipid bilayer of the exosome to recipient 
cells can induce those cells to change cellular characteristics [8]. STAT3 is found 
in exosomes and promotes angiogenesis, improves fibroblast proliferation, 
and decreases the amount of time needed to heal an injury [9]. In regenerative 
medicine, it has been noted that paracrine signaling can generate up to 91% of 
the effects of injected stem cells [10]. Thus, the use of exosomes obtained from 
conditioned media used in cell culture has rapidly become popular in many spe-
cialties including cardiology, orthopedics, oncology, and the esthetic field [11]. 
Esthetic applications include topical application following nonthermal micronee-
dling, RF microneedling, fractional laser resurfacing, and plasma-driven resur-
facing. In these instances, reduction of downtime and improvement in skin tone 
and texture have been noted [12]. The FDA issued a statement [13] in December 
2019 that, as yet, no exosomes have been cleared by the agency; therefore, 
topical use only is advised. Because the product is acellular, many companies 
producing these products note that they are exempt from FDA scrutiny or GMP 
manufacturing processes. However, since the FDA classifies any biological that 
is intended to penetrate the stratum corneum in order to change the structure 
or function of any aspect of the human body as a drug, practitioners who inject 
exosomes are violating FDA guidelines [14].
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Polydioxanone (PDO) threads have become popular worldwide over a period 
of approximately 5 years. These threads can be used in place of fillers for such 
purposes as dorsal nasal augmentation, improvement of deep dermal or superficial 
hypodermal defects, and focal depressions. Improvement of skin laxity by using 
barbed threads as suspension devices is also growing again in popularity. While 
barbed threads originated more than 20 years ago, the early devices were created 
by hand cutting existing sutures, creating a weak spot at the base of the cut in the 
thinnest area of the suture diameter. Early threads were notorious for breakage, 
extrusion, and “cheese wiring” or cutting through soft tissue to extrude through the 
skin [15]. The “lunchtime facelift” was performed using percutaneous threads that 
could create bunching and superficial contour irregularities. Patients noted either 
little result in many cases or complained about the lack of longevity. The use of 
permanent sutures resulted in a mixture of good and not so good results. This his-
tory parallels that of permanent fillers: an irreversible outcome has no easy solution 
if a problem arises [16]. Thus, many practitioners are now choosing threads that are 
resorbable over time.
Because regeneration of the subcutaneous layer is as important as skin reju-
venation, the emphasis on biostimulatory products has increased during recent 
years. Erosion of the collagen matrix that binds the adipose framework support-
ing the overlying skin has been well documented (Figure 1). Restoration of the 
collagen and elastin fraction of the fibroseptal network has been noted primarily 
with radiofrequency-assisted soft tissue stimulation [17]. Poly-L-lactic acid can 
also stimulate collagen formation over time. Because it is sometimes difficult to 
get the compound into solution and because it is somewhat expensive to the con-
sumer, widespread adoption of this injectable has lagged behind acceptance of 
HA and hydroxylapatite fillers. Late granuloma formation is also a deterrent to its 
use [18]. First popularized in Asia, PDO (polydioxanone) threads [19] have been 
rapidly accepted in that part of the world. Advantages include longevity similar 
to that of fillers with a significantly lower product cost. Ease of administration 
is a plus, and the lack of intravascular accidents due to the mechanics of threads 
offers a superior safety profile. PDO threads are available in several styles. 
“Mono” threads are used in the deep dermis or in the superficial hypodermis. 
They are usually injected in a stacked pattern (nasal dorsum) for filling volume-
deficient regions. They can also be placed in a crosshatched “woven” pattern to 
stimulate soft tissue neocollagenesis in a pattern similar to that of Sculptra. The 
effect of small diameter threads can be subtle, but these are excellent for use in 
patients with very thin skin.
Figure 1. 
Scanning electron micrographs of aging adipose tissue. (A) A 23-year-old shows a dense three-dimensional 
“net” of collagenous stroma forming a scaffold that holds adipose cells in a firm and defined shape. (B) In 
middle age an irregular erosion of this framework is apparent. (C) A 61-year-old patient shows complete loss 
of the fibroseptal network that shapes and supports the subcutaneous adipose layer.
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Early manufacture of barbed threads involved several cuts after manufacturing 
of the suture, but this can cause weak points as noted, and therefore breakage can 
be problematic. Molded threads retain their central integrity, so tensile strength 
is improved. Cogs or cones can be used instead of or in addition to barbs in order 
to secure tissue attachment. A new double-coated polydioxanone thread com-
bines these two modalities in order to strongly secure soft tissue. These threads 
have a 2-year effect; when the outer layer erodes and resorbs, the inner thread 
remains intact.
A new thread type unique to the Miracu (Mission Viejo, CA) company is known 
as Meshfill TM. These filler threads consist of 16 tiny woven PDO threads formed 
into a hollow cylinder. They can be used alone or in combination with fat or filler. 
When filled with the correct amount of complementary filler, the product can be 
contained in the cylinder’s space. Meshfill can be stacked in area needing more 
volume, such as the cheeks or chin. When used with autologous fat transfer, the 
volume correction is retained as the fat becomes newly vascularized. Meshfill 
can be used in difficult-to-treat regions such as the infraorbital region and oral 
commissures.
3. Materials and methods
Topical exosomes are available in the USA from several commercial produc-
ers. Benev (Mission Viejo, CA) currently offers the most cost-effective version. 
Because the FDA considers any formulation intended to change the structure 
or function of a human that is administered deeper than the stratum corneum 
[14], the use of exosomes is now limited to cosmetic use as a topical applica-
tion. The Benev formulation consists of two vials. One vial contains lyophilized 
exosomes that are to be reconstituted and are obtained from progenitor cells 
treated with conditioned media. The second vial of diluent contains hyaluronic 
acid, which is a strong hydrator, plus multiple growth factors and small pep-
tides. Once mixed, the preparation should be refrigerated. The solution can be 
applied topically to the skin on label. Exosomes are also used following treat-
ment with microneedling, nitrogen plasma resurfacing, application of radiofre-
quency energy, fractional laser, and dermaplaning in order to optimize rapid 
healing. Ideally several serial applications should be made in order to obtain the 
most benefit.
PDO threads can be added to the skin treatment in order to improve the tone 
and laxity of the subcutaneous layer. The biostimulatory nature of PDO threads is 
seen in Figure 2. A small collagenous tunnel develops over 1 month, surrounding 
the thread as it gradually resorbs. This soft tissue support remains after the thread 
itself disappears. Most esthetic practitioners employ combination treatments in 
order to optimize outcomes for their aging patients, as a single solution generally 
does not address all defects. Three areas of subcutaneous improvement can be 
targeted. Problems addressed include mild to moderate soft tissue atrophy; this 
type of defect may be best treated with mono threads. Soft tissue laxity and mild to 
moderate pendulosity of the jowls and nasolabial folds are usually addressed with 
barbed threads. The longer lasting threads are recommended for use by skilled 
practitioners as these can be difficult to remove. Focal volumetric defects such 
as prejowl sulcus, gonial notching, a retrusive chin, drooping oral commissures, 
infraorbital hollowing, and the depression associated with malar bags all respond 
well to Meshfill injection. Excellent correction of deep nasolabial folds is also seen 
with Meshfill.
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The patient should be marked in the upright position prior to thread inser-
tion. Injection can be performed either upright or in a semirecumbent position. 
However, when tightening barbed threads, this is best done while the patient is 
upright. Markings are performed with a brow pencil prior to thread insertion. The 
vector of tightening is calculated. Generally, two or three threads are needed per 
region for optimal effect. Application of topical anesthesia prior to treatment is 
routinely performed. Removal of the topical anesthetic along with sterile prep and 
drape is the standard of care. Hair is contained so that thread contact is minimized. 
While mono threads are commonly injected without local anesthetic, a small 
amount of intradermal local anesthesia greatly improves patient comfort. With 
barbed thread insertion and Meshfill injection, it is recommended to numb both 
the insertion site and the line or track along which the thread will be placed. Only 
a small amount of lidocaine is needed per region. The use of 0.5 or 1% lidocaine 
with epinephrine will minimize bruising if injected in full 3 minutes prior to thread 
insertion. An insertion point for the cannula is placed approximately 0.5–1 cm 
proximal to the region to be filled. Thus, the thread should be held in place over the 
treatment target prior to choosing an access point, in order to be sure the thread 
length is correct. The importance of this point cannot be overstated. If not injected 
well beyond the actual treatment target, threads can migrate, and the ends can 
create a superficial deformity.
4. Results
Combination therapy, especially when performing microlifting, generally 
produces a more profound improvement than when using a single treatment 
modality. Triple treatments for face and neck rejuvenation in patients seeking 
minimal recovery time include light fractional resurfacing or nitrogen plasma 
resurfacing, application of exosomes to the treatment region for enhanced 
outcome and rapid healing, and volumization and tissue suspension with PDO 
threads. In many states, these treatments can be delegated to a licensed super-
vised provider.
It is recommended that only skilled physicians inject Meshfill or Line threads, as 
the treating provider should be able to take care of any potential complication that 
might occur.
Figure 2. 
Polydioxanone thread hollow and granulation tissue with newly made collagen fibers, 1 month after thread 
insertion, White Yucatan pig study. Source: Research by Yonsei Clinical Medicine Research Center, Dr. Junghyun 
Yoon, and Dr. Sangseob Kim with N-Finders Co., Ltd.
Cosmetic Surgery
6
Figure 3 illustrates the case of a 56-year-old patient who sought treatment 
for infraorbital hollowing. She had filler injections as well as autologous fat 
grafting. Her result following Meshfill injection plus fat introduced into the 
cylinder shows a dramatic correction in an area that is historically difficult to 
treat. Meshfill insertion in this region is below the orbicularis muscle at the level 
of the orbital rim. A 30 mm length was used in order to reduce the risk of thread 
visibility. In patients with lateral hollowing, the use of two shorter threads per 
region can yield more accurate placement than a single longer thread in this 
curved region.
Figure 4 shows a 74-year-old with drooping oral commissures and general 
volume loss. Meshfill was injected into the oral commissures in an “X” dis-
tribution so that the threads were stacked at the point of deepest depression. 
30 mm threads were used at this location in combination with 0.2 cc Restylane 
Figure 4. 
(A) A 74-year-old patient with age-related soft tissue atrophy. (B) Two-week postinjection of Meshfill plus 
intraluminal injection of 0.2–0.3 cc HA filler per site: Cheeks, perioral, and infraorbital regions.
Figure 3. 
(A) A 56-year-old patient before treatment. Previous infraorbital treatments included filler and fat grafting. 
(B) The same patient 2 weeks postinjection of Meshfill PDO cylinders plus 0.2 cc hyaluronic acid filler per side.
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per injection site. 40 mm Meshfill was stacked in the malar region in order to 
achieve volumetric enhancement.
Figure 5 denotes a 53-year-old patient treated with a combination of barbed 
threads and Meshfill in the brow region. The often flat supraorbital rim can be 
contoured and lifted using this unique combination (Figure 6).
Figure 7 depicts the improvement in rapidity of healing that can be achieved by 
applying topical exosomes. Normally, fully ablative erbium laser resurfacing takes 
7–10 days to fully re-epithelialize. This patient had full skin surface repopulation in 
5 days. Application of exosomes, then Aquaphor ointment, was performed twice a 
day for 2 days.
Figure 5. 
(A) A 53-year-old patient noting a flattening of the supraorbital rim and loss of brow structure. (B) Two-
week post-insertion of two PDO barbed threads per lateral brow plus injection of Meshfill and 0.3 cc HA filler 
underneath the brow itself.
Figure 6. 
(A) A 75-year-old before RF needling, laser resurfacing, fat grafting, and exosome application. (B) Two 
days post-treatment, most areas have re-epithelialized. Usually this process takes 6–8 days. (C) One month 
post-treatment, the patient’s facial contour and jawline has changed dramatically. No surgical facelift was 
performed.
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5. Discussion
Botulinum toxin and fillers have been the standard introductory maintenance 
treatment for the improvement of age-related lines and volumetric lines for many 
years. “Filler fatigue” is a growing phenomenon, especially when the cost of treat-
ment is calculated. As with any repeated procedure, the cost is not only monetary. 
For most patients, time spent recovering from a procedure, which limits their ability 
to work or enjoy leisure activities, is a real concern. Many tend to choose a lesser 
procedure based solely on “down” time. The lack of longevity with filler and toxin 
injections is a common complaint. As patients age, many note that the problem they 
are experiencing cannot be adequately addressed with these two types of injections. 
Regenerative options are being sought as an alternative to standard approaches, as 
restoration of one’s own tissues is preferred to injecting toxins or foreign substances. 
Microlifting [20], a term coined by Tiryaki, is an approach that generally combines 
subcutaneous thread placement with other regenerative approaches.
While stem cell therapy is regarded as the highest form of regenerative 
medicine, recent research disputes that conventional wisdom. Many papers in 
different specialties note that cell-to-cell signaling has much more of an effect at 
the treatment target than the progenitor cells themselves do [21]. Exosomes are 
present in all tissues. They are formed when endosomes, or intracellular multive-
sicular particles, fuse with the cell’s plasma membrane. Smaller nanoparticulate 
vesicles “bud out” into the intercellular space (Figure 8). Exosomes are able to 
communicate with other cells without making direct contact. In the early 1980s, 
exosomes were thought to be a receptacle for intracellular waste. Named in 1987, 
exosomes [22] were found to be the messengers that transfer behavior instruc-
tions to a recipient cell located in the region. The “paracrine effect” is the way that 
exosomes communicate with target cells (Figure 7). These nanoparticles generally 
measure 20–100 microns and less than 0.1 micron. They reside within endosomes, 
which are multivesicular organelles located within the cell. After binding with the 
internal plasma membrane, these nanoparticles are released outside the cell. Able 
to communicate with multiple cells in the region, exosomes are capable of induc-
ing a change in behavior of a nearby cell without depending on direct cell contact. 
Figure 7. 
Diagram of intracellular exosomes.
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They contain messenger RNA, microRNA, proteins, lipids, cytokines, bioactive 
compounds, and nucleic acids [23]. Figure 9 shows the formation of exosomes from 
intracellular endosomes. Exosomes have been shown to promote proliferation of the 
target cell and more rapid healing than with a PBS buffer or depleted media in vitro 
[24]. Repair of injury with exosomes was noted to be three times as fast as the injury 
Figure 8. 
(A) Autrocrine signaling occurs when intracellularly derived particles influence the same cell at the 
extracellular membrane level. (B) Paracrine signaling occurs when exosomes are released into the extracellular 
fluid, thus influencing the behavior of cells within the local region. (C) Direct cell to cell communication can 
occur when adjacent cells build nanotunnels through which intracellular proteins and RNA is shared. (D) 
Endocrine signaling occurs when a substance such as a hormone enters the nearby bloodstream, influencing 
cellular behavior in a distant location.
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treated with buffer alone and two times as fast as the region treated with depleted 
media. The response was dose related; the dose of 10 mcg/ml seemed optimal in 
laboratory conditions. Clinical use of topical exosomes is noted to improve healing 
in patients who undergo fractional resurfacing procedures.
6. PDO threads
Alcamo was the first to use barbed threads and is given credit for his invention in 
1964 [25]. These threads were hand cut and barbs were unidirectional. MacKenzie 
[26] is credited with the development of the bidirectional barbed thread. In the late 
1980s, Sulamanidze noted the use of modified polypropylene sutures for subcuta-
neous facial lifting without skin excision [27]. Aptos threads were developed and 
became popular for improving soft tissue pendulosity since little downtime was 
required. While some patients experienced good results, many major complications 
were reported, including breakage, rippling, facial distortion, extrusion, infection, 
and cheese wiring of the suture through the skin [28]. Wu [29] developed his own 
version of a barbed thread and noted that all effects were lost over time; patients 
needed to repeat the procedure in order to retain benefit. Ruff was awarded a patent 
for developing a barbed thread in 1994, with his first prototype a weed whacker cord 
[30]. FDA clearance in the USA was achieved in 2004, when a polypropylene, then 
later a polydioxanone device, was developed by Quill. Shortly thereafter, the contour 
thread was withdrawn from the market. At the time, threads had attained some noto-
riety due to a combination of use by poorly trained individuals and a rash of publi-
cized complications. Threads have made a bit of a comeback, as better training and 
safer resorbable sutures are being introduced. Currently there are several remaining 
barbed sutures available in US origin. Stratafix, a permanent barbed suture by 
Ethicon, has been discontinued in practice due to the intense fibrotic response and 
patient complaints of inflammation and discomfort in the treatment region. V-lock is 
resorbable and seems better tolerated, especially in breast surgery. Silhouette is FDA 
cleared for midface lifting [30] and also claims to be biostimulatory [31]. Since 2015, 
several companies have applied for FDA clearance of their polydioxanone threads for 
the approximation of the skin. Miracu threads [32] have received FDA clearance for 
both the PDO thread and the cannula insertion device.
Many styles of PDO threads are available. Filler threads have no fixation and are 
intended to supply a small amount of volume as well as hypodermal stimulation. 
Bidirectional barbed threads can be placed with a needle from the center of the treat-
ment region. An alternative is the placement of these threads from within a cannula 
which avoids a central puncture mark. “Spring” threads are used in areas where 
Figure 9. 
Clinical effect of exosomes. (A) A 62-year-old patient 2 days following ablative erbium laser resurfacing. 
(B) The same patient on day 5. Usually these patients require 7–10 days of healing in order to achieve 
re-epithelialization.
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dynamic motion is prominent and might be restricted with a linear model. The novel 
Meshfill device (Figure 10) is a cylinder made of 16 tiny woven PDO threads that is 
inserted within a cannula. Prior to cannula withdrawal, 0.2 cc of either filler or fat can 
be injected into the internal space. The concept of an injectable implant has a great util-
ity. In regions where a firm or defined contour is needed—the chin, cheek, or jawline, 
for example—these devices can be stacked or lined up to dramatically enhance shape. In 
regions where a linear depression is noted—the nasolabial fold—dramatic rather than 
subtle correction can be obtained with a very small amount of additional filler or fat.
Figure 10. 
Diagram of Meshfill construction. Sixteen tiny PDO threads are woven and placed on a 21 gauge cannula. 
These cylindrical structures can be used as filler threads by themselves or can be filled with fat or fillers to 
augment the volumetric correction.
Figure 11. 
Miracu line thread. This PDO thread employs barbs and cogs in a double-coated structure that lasts up to 
2 years.
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A new addition to the portfolio is a double-coated PDO thread that combined 
barbs and cogs. The Miracu Line TM device is molded, not cut, so there is no weak 
point along the thread (Figure 11). The thread called “Line” lasts for 2 years. As the 
outer coating is resorbed, the inner thread maintains a presence and continues to 
offer soft tissue support. Because of the semipermanent nature of the Line thread, it 
is recommended that only skilled physicians use the device, with care taken to place 
it deep enough so that a contour defect is avoided. Manipulation of these threads 
should not be overdone as they are difficult to remove.
7. Conclusion
While patient acceptance of injectables has been high, many educated 
consumers are now seeking regenerative solutions for their esthetic needs. 
Combination treatment of the skin and subcutaneous stromal scaffold is attrac-
tive to both patients and physicians. The use of exosomes to signal cells in the 
treatment region is a rapidly growing trend. When combined with a light resur-
facing protocol, exosomes accelerate the healing process while delivering mRNA, 
cytokines, chemokines, and growth factors. Restoration of the support system of 
the skin, the subcutaneous stroma, can be enhanced with PDO resorbable threads 
that are biostimulatory. Mono threads will generate directional collagen ingrowth 
in the superficial hypodermis. Barbed suspension threads can support sagging 
regions. Cylinder configured threads can be used alone or in combination with 
filler or fat. These injectable implants can replace small surgically introduced 
facial implants in many cases. Microlifting using suspension threads combined 
with regenerative techniques is a popular alternative to traditional injectable 
techniques.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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